• 303 Citations
  • 10 h-Index
20092020

Research output per year

If you made any changes in Pure these will be visible here soon.

Personal profile

Education

  • 2010 陽明大學公共衛生學研究所博士
  • 2004 臺灣大學流行病學研究所碩士
  • 2002 高雄醫學大學公共衛生學系學士

Experience

  • 2017- 臺北醫學大學醫學檢驗暨生物技術學系副教授
  • 2015- 臺北醫學大學醫學生物科技博士學位學程籌備處助理教授
  • 2012-2017 臺北醫學大學醫學檢驗暨生物技術學系助理教授 
  • 2012 臺北醫學大學醫學檢驗暨生物技術學系助理研究員
  • 2010-2012 國立陽明大學博士後研究

Fingerprint Dive into the research topics where Yi-Jen Liao is active. These topic labels come from the works of this person. Together they form a unique fingerprint.

  • 2 Similar Profiles

Network Recent external collaboration on country level. Dive into details by clicking on the dots.

Projects

探討NPC2基因調控肝癌細胞內游離型膽固醇恆定在sorafenib抗藥性之角色(2/3)

Liao, Y.

8/1/207/1/21

Project: A - Government Institutionb - Ministry of Science and Technology

Study the Roles of Npc2 Mediated Free Cholesterol Homeostasis in the Sorafenib-Resistant Hepatocellular Carcinoma( I )(1/3)

Liao, Y.

8/1/197/31/20

Project: A - Government Institutionb - Ministry of Science and Technology

Study the Therapeutic Role of Niemann-Pick Type C2 Protein in the Inhibition of Hscs Activation and Liver Fibrosis Treatment

Liao, Y.

8/1/187/1/19

Project: A - Government Institutionb - Ministry of Science and Technology

Study the Roles of Npc2 in the Regulation of Hepatic Stellate Cells Activation and Liver Fibrosis

Liao, Y.

8/1/177/31/18

Project: A - Government Institutionb - Ministry of Science and Technology

探討新型benzimidazole衍生物抑制肝癌抗藥性細胞生長的角色

Liao, Y.

7/1/172/28/18

Project: A - Government Institutionb - Ministry of Science and Technology

Research Output

  • 303 Citations
  • 10 h-Index
  • 45 Article
  • 3 Letter
  • 1 Comment/debate
Open Access
  • Open Access
  • 2 Citations (Scopus)

    Characteristics of CD133-Sustained Chemoresistant Cancer Stem-Like Cells in Human Ovarian Carcinoma

    Liu, C. L., Chen, Y. J., Fan, M. H., Liao, Y. J. & Mao, T. L., Sep 4 2020, In : International journal of molecular sciences. 21, 18

    Research output: Contribution to journalArticle

    Open Access
  • Engineering Chimeric Antigen Receptor T Cells against Immune Checkpoint Inhibitors PD-1/PD-L1 for Treating Pancreatic Cancer

    Yang, C. Y., Fan, M. H., Miao, C. H., Liao, Y. J., Yuan, R. H. & Liu, C. L., Jun 26 2020, In : Molecular Therapy - Oncolytics. 17, p. 571-585 15 p.

    Research output: Contribution to journalArticle

    Open Access
  • Open Access